Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $3.44 million which missed the analyst consensus estimate of $3.98 million by 13.59 percent. This is a 14.10 percent increase over sales of $3.01 million the same period last year.
Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.